Skip to main content

Market Overview

28 Stocks Moving In Monday's Mid-Day Session



  • Clearside Biomedical Inc (NASDAQ: CLSD) surged 45.2 percent to $11.35 after the clinical biopharmaceutical company announced an encouraging update from ongoing clinical studies. The company said its pivotal phase 3 clinical trial of its suprachoroidal CLS-TA in patients with macular edema achieved positive topline results.
  • Innovate Biopharmaceuticals Inc (NASDAQ: INNT) shares surged 40.9 percent to $13.36 after climbing 54.15 percent on Friday.
  • XL Group Ltd. (NYSE: XL) shares gained 29.3 percent to $55.99 after the insurance company agreed to sell itself to France's AXA for $15 billion, or $57.60 per share.
  • Carver Bancorp Inc (NASDAQ: CARV) shares rose 26.1 percent to $3.62.
  • Vericel Corp (NASDAQ: VCEL) shares climbed 25.2 percent to $10.45 following better-than-expected Q4 earnings.
  • GTx, Inc. (NASDAQ: GTXI) rose 21.5 percent to $20.43 as the company issued Phase 2 data for enobosarm for urinary incontinence.
  • iPic Entertainment Inc (NASDAQ: IPIC) surged 18.2 percent to $13.38. Roth Capital initiated coverage on iPic Entertainment with a Buy rating and a $18.00 price target.
  • ITUS Corp (NASDAQ: ITUS) shares gained 10.8 percent to $3.61 after the company reported a partnership with Serametrix for ITUS' Cchek.
  • Intrepid Potash, Inc. (NYSE: IPI) climbed 10.7 percent to $3.94. Cowen & Co. upgraded Intrepid Potash from Underperform to Market Perform.
  • Dragon Victory International Limited (NYSE: LYL) shares rose 10.2 percent to $3.78.
  • Tenax Therapeutics Inc (NASDAQ: TENX) gained 10 percent to $8.47 after dropping 27.36 percent on Friday.
  • Casa Systems Inc (NASDAQ: CASA) shares gained 9.1 percent to $23.94.
  • Tyme Technologies Inc (NASDAQ: TYME) climbed 7.9 percent to $2.47.
  • Alliance One International, Inc. (NYSE: AOI) shares rose 7.2 percent to $23.20
  • Aimmune Therapeutics Inc (NASDAQ: AIMT) shares gained 6.8 percent to $36.39 after the company presented results from its pivotal Phase 3 PALISADE trial of AR101 for peanut allergy at the AAAAI-WAO.
  • ACM Research Inc (NASDAQ: ACMR) gained 6.4 percent to $7.70 after the company reported upbeat Q4 results.
  • MacroGenics Inc (NASDAQ: MGNX) climbed 6.3 percent to $30.75. H.C. Wainwright initiated coverage on MacroGenics with a Buy rating.
  • Groupon Inc (NASDAQ: GRPN) rose 5 percent to $4.48. Morgan Stanley upgraded Groupon from Underweight to Equal-Weight.
  • Corindus Vascular Robotics Inc (NYSE: CVRS) gained 4 percent to $1.09. The developer of precision vascular robotics announced it has received a 510(k) clearance from the U.S. Food and Drug Administration for its automated robotic movement designed for the CorPath GRX platform.

Check out these big penny stock gainers and losers


  • Dermira Inc (NASDAQ: DERM) shares tumbled 63.2 percent to $9.27 as the company disclosed that its two Phase 3 trials evaluating olumacostat glasaretil in patients with acne vulgaris did not meet co-primary endpoints.
  • Sparton Corporation (NYSE: SPA) declined 24.3 percent to $17.28 after the company reported termination of merger agreement with Ultra.
  • Smith Micro Software, Inc. (NASDAQ: SMSI) fell 23.4 percent to $1.65 as the company announced a $5 million private placement.
  • BRF SA (ADR) (NYSE: BRFS) shares dropped 14.5 percent to $8.05.
  • Babcock & Wilcox Enterprises Inc (NYSE: BW) fell 11.8 percent to $4.87. Wynnefield Capital disclosed that it will fully subscribe to Babcok & Wilcox's rights offering.
  • Nextdecade Corp (NASDAQ: NEXT) shares dropped 11.1 percent to $5.61.
  • USA Truck, Inc. (NASDAQ: USAK) fell 11 percent to $22.88.
  • Vectrus Inc (NYSE: VEC) slipped 8 percent to $34.00. Drexel Hamilton downgraded Vectrus from Buy to Hold.
  • United Bancshares Inc. OH (NASDAQ: UBOH) shares declined 7.3 percent to $20.40.

Related Articles (ACMR + AIMT)

View Comments and Join the Discussion!

Posted-In: Losers Mid-Day MoversNews Movers & Shakers Intraday Update Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at